Middle East & Africa Pen Needles Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Pen needles come in a variety of lengths and widths to suit all body types. They are used to be long and sharp, but due to evolutions in technology, needles are now small, thin and quite often pain-free. From 12mm to 4mm, the needle length you choose is likely to be dictated by your size. Children will likely benefit from them shorter 6mm size.

The Middle East & Africa Pen Needles Market Segments Size & Growth:

The Middle East & Africa Pen Needles Market size is projected to reach approximately $0.36 billion by the end of 2024 with a CAGR of close to 8.67% from $0.23 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include rising diabetes prevalence, a comparative advantage over syringes and vials, technological advancements, increasing awareness of the general public, government support in certain countries. However, reusability of pen needles, complications associated with needle use, availability of alternative dosage forms, poor reimbursement policies in underdeveloped and developing countries are thereby hampering the market growth.

The Middle East & Africa Pen Needles Market Segments Share:

The Middle East & Africa Pen Needles Market is categorised into therapy which comprises growth hormone, Insulin, and GLP-1. Among them, insulin therapy segment is expected to hold the largest share in the market. By Type, the market is segmented into standard pen needles and safety pen needles. Among them, standard pen needles segment is expected to account for the largest share in the pen needles market because of rising prevalence of diabetes and dysfunctionality of pancreas. By Needle Length, the market is segmented into 4mm, 6mm, 8mm, 10mm, and 12mm. Among them, 8mm needle length segment is expected to hold for the largest share in the market. By Material, the market is segmented into glass needles, plastic needles, stainless steel/metallic needles, and polyetheretherketone (PEEK) needles. By Mode of Purchase, the market is segmented into retail and non-retail. Among them, retail purchase mode segment is expected to hold the largest share in the market. By Type of Therapy, the market is segmented into glucagon-like peptides, insulin, growth hormones, among others. By End-Users, the market is segmented into hospitals, diagnostic centres, home healthcare, and others. By Geography, Middle East is projected to hold for the largest share because of huge profit margins and growth prospects.

The Middle East & Africa Pen Needles Market Trends:

• Novo Nordisk is planning to launch a new product called flex pro; the device is designed to hide the needle injecting Norditropin into patients. Norditropin is used for children and adolescents.
• Becton, Dickinson, and Company announced the introduction of the BD Ultra-Fine micro pen needle 6mm x 32G for use with leading pen injection devices.

The Middle East & Africa Pen Needles Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

• Becton, Dickinson, and Company
• Novo Nordisk A/S
• Ypsomed Holding AG
• Smiths Medical
• Allison Medical, Inc.